Early-stage drug discovery is rapidly evolving into an endeavour in which scientific research communities in both the public and private sectors are finding new ways to share knowledge, expertise and resources. Here, we discuss some of the challenges for such collaborations and highlight examples in which traditional barriers such as intellectual property concerns have been addressed.
- Peter B. Simpson
- Melvin Reichman
